Ketamine for Post-operative Analgesia in Hemorrhoidectomy

Part of paid clinical trials in Oklahoma City, Oklahoma.

Sponsor
University of Oklahoma
Study ID
NCT04248205
Phase
PHASE4
Status
Recruiting

Conditions

  • Hemorrhoids

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Ketamine — DRUG
    Standard general anesthesia PLUS ketamine will be given for post-operative analgesia

Study Details

This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine is administered. The investigators will know whether the participant receives ketamine or not.

Key Dates

Start date
Jun 15, 2020
Status verified
Mar 2026
Primary completion
Jan 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Intraoperative ketamine infusion
    Subjects in this group will receive standard anesthesia during surgery and a dose of ketamine at 0.3 mg/kg IV bolus prior to surgical incision. If the procedure lasts more than 1 hour, an additional bolus dose will be given.
  • No Intervention: Control group
    This group will only receive the standard anesthesia during surgery with no ketamine.

Primary Outcome Measure

Change in post-operative narcotic usage [ Time Frame: two weeks post-operation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Oklahoma Health Sciences CenterOklahoma CityOklahoma73104
Steven Carter
405-271-8001

Find similar trials in Oklahoma City, OK